Recommendation of the President – on the legitimacy of changing the medical technology for the guaranteed health care services within the scope of ICD-9 procedures: 84.502 – introduction of growth factors of autologous origin and 84.503 – introduction of growth factors from stem cells
On 31 May 2022 the President of the Agency for Health Technology Assessment and Tariff System issued the following recommendation:
Recommendation No. 50/2022 of 31 May 2022of the President of the Agency for Health Technology Assessment and Tariff System on the legitimacy of changing the medical technology for the guaranteed health care services within the scope of ICD-9 procedures: 84.502 – introduction of growth factors of autologous origin and 84.503 – introduction of growth factors from stem cells